首页|自制体外膜肺氧合系统救治危重症患者的装机策略和临床观察

自制体外膜肺氧合系统救治危重症患者的装机策略和临床观察

扫码查看
目的 总结危重症患者采用自制体外膜肺氧合(ECMO)系统辅助治疗的策略与方法.方法 采用观察性研究方法,选择2020年12月至2021年12月在阜外华中心血管病医院进行ECMO辅助支持的56例心血管危重症患者作为研究对象,根据患者临床情况并结合家属意愿选择使用常规ECMO套包(常规组)或自制ECMO套包(自制组).常规组采用一次性使用ECMO套包进行装机、预充排气等操作;自制组采用心脏手术体外循环中常规使用的一次性耗材(包括离心泵头、膜肺、管道、连接头等)自制ECMO系统,针对患者情况进行个体化的管路型号选择和长短控制.记录两组ECMO系统装机准备时间、辅助时间、辅助方式、总体预充量、ECMO运转2 h后游离血红蛋白(FHb)水平和上机费用,以及置入ECMO后48 h内血流动力学、动脉血气分析和血液指标的变化;同时观察两组患者ECMO辅助治疗过程中ECMO系统相关不良事件发生情况.结果 56例患者均纳入最终分析,常规组与自制组各28例,均成功完成ECMO辅助治疗.常规组与自制组ECMO系统装机准备时间、辅助时间、辅助方式、ECMO运转2 h后FHb水平差异均无统计学意义[装机准备时间(min):13±4比15±5,辅助时间(h):287±34比276±42,静脉-动脉ECMO(例):22比24,静脉-静脉ECMO(例):6比4,ECMO运转2 h后FHb(mg/L):226±67比253±78,均P>0.05];但自制组总体预充量和上机费用明显少于常规组[总体预充量(mL):420±25比650±10,上机费用(万元):3.8±0.4比6.7±0.3,均P<0.01].两组患者上机后48 h内血流动力学、动脉血气分析和血液指标均处于相对稳定状态,且两组间大部分指标差异无统计学意义;自制组上机后12、24、48 h血红蛋白(Hb)水平明显高于常规组(g/L:12 h为128.5±23.7比117.5±24.3,24 h为 121.3±31.3 比 109.6±33.2,48 h 为 118.5±20.1 比 105.2±25.7,均 P<0.05).两组患者在 ECMO 辅助治疗过程中均未出现膜肺渗漏、接头脱落、大量溶血等ECMO系统相关不良事件.结论 临床针对危重症患者实施ECMO时,可以利用心脏手术体外循环中常规使用的一次性耗材自制ECMO系统进行心肺功能辅助支持,从而节省患者的医疗费用,缓解临床上对一次性ECMO套包的依赖.
Installed strategy and clinical observation of self-made extracorporeal membrane oxygenation system in the treatment of critically ill patients
Objective To summarize the strategy and method for the treatment of critically ill patients with self-made extracorporeal membrane oxygenation(ECMO)system.Methods A observative study was conducted.Fifty-six patients with ECMO assisted support in Fuwai Central China Cardiovascular Disease Hospital from December 2020 to December 2021 were enrolled.According to the clinical situation of the patients and the wishes of the family,conventional ECMO package(conventional group)or self-made ECMO package(self-made group)was chosen.In the conventional group,the disposable ECMO package was used to install the machine,pre charge and exhaust the air.In the self-made group,the disposable consumables commonly used in extracorporeal circulation during cardiac surgery(including centrifugal pump heads,membrane oxygenation,tubes,connectors,etc.)were used to create a self-made ECMO system.Based on the patient's situation,personalized tube model selection and length control were carried out.The preparation time,auxiliary time,auxiliary method,total pre charge volume,free hemoglobin(FHb)levels after 2 hours of ECMO operation and operating costs,as well as changes in hemodynamics,arterial blood gas analysis,and blood indicators within 48 hours after ECMO placement in the two groups were recorded.The occurrence of adverse events related to the ECMO system during ECMO adjuvant therapy in two groups was simultaneously observed.Results Fifty-six patients were enrolled finally,with 28 cases in the conventional group and 28 cases in the self-made group,and all successfully completed the operation of ECMO.There was no statistically significant difference in ECMO system preparation time,auxiliary time,auxiliary method,and FHb levels after 2 hours of ECMO operation between the conventional group and the self-made group[preparation time(minutes):13±4 vs.15±5,auxiliary time(hours):287±34 vs.276±42,veno-arterial ECMO(cases):22 vs.24,veno-venous ECMO(cases):6 vs.4,FHb after 2 hours of ECMO operation(mg/L):226±67 vs.253±78,all P>0.05].However,the total pre charge volume and operating costs in the self-made group were significantly lower than those in the conventional group[total pre charge volume(mL):420±25 vs.650±10,operating costs(ten thousand yuan):3.8±0.4 vs.6.7±0.3,both P<0.01].The hemodynamics,arterial blood gas analysis,and blood indicators of patients in the two groups were relatively stable within 48 hours after ECMO operation,and most of the indicators between the two groups showed no statistically significant differences.The hemoglobin(Hb)levels at 12,24,and 48 hours after the machine transfer in the self-made group were significantly higher than those in the conventional group(g/L:128.5±23.7 vs.117.5±24.3 at 12 hours,121.3±31.3 vs.109.6±33.2 at 24 hours,118.5±20.1 vs.105.2±25.7 at 48 hours,all P<0.05).Both groups of patients did not experience any adverse event related to the ECMO system,such as membrane pulmonary infiltration,joint detachment,and massive hemolysis,during the ECMO assisted treatment process.Conclusion When implementing ECMO for critically ill patients in clinical practice,a self-made ECMO system with disposable consumables commonly used in extracorporeal circulation during cardiac surgery can be used for cardiopulmonary function assistance support,thereby saving patients medical costs and alleviating their dependence on disposable ECMO package in clinical practice.

Extracorporeal membrane oxygenationExtracorporeal circulationExtracorporeal membrane oxygenation package

陈月、钱晓亮、豆立冬、李建朝

展开 >

河南省人民医院(阜外华中心血管病医院)麻醉与围术期医学科,郑州 450000

河南省人民医院(阜外华中心血管病医院)体外循环科,郑州 450000

体外膜肺氧合 体外循环 体外膜肺氧合套包

河南省郑州市科技惠民计划河南省郑州市重点实验室建设项目

2022KJHM00362019-80

2024

中华危重病急救医学
中华医学会

中华危重病急救医学

CSTPCD北大核心
影响因子:3.049
ISSN:2095-4352
年,卷(期):2024.36(4)